Virtual screening with flexible docking and COMBINE-based models. Application to a series of factor Xa inhibitors.

A two-step, fully automatic virtual screening procedure consisting of flexible docking followed by activity prediction by COMparative BINding Energy (COMBINE) analysis is presented. This novel approach has been successfully applied, as an example with medicinal chemistry interest, to a recently reported series of 133 factor Xa (fXa)(1) inhibitors whose activities encompass 4 orders of magnitude. The docking algorithm is linked to the COMBINE analysis program and used to derive independent regression models of the 133 inhibitors docked within three different fXa structures (PDB entries 1fjs, 1f0r, and 1xka), so as to explore the effect of receptor conformation on the overall results. Reliable docking conformations and predictive regression models requiring eight latent variables could be derived for two of the fXa structures, with the best model achieving a Q(2) of 0.63 and a standard deviation of errors of prediction (SDEP) of 0.51 (leave-one-out). The two-step procedure was then employed to screen a designed virtual library of 112 ligands, containing both active and inactive compounds. While docking energies alone could show a good performance for selecting hits, including structurally diverse ones, inclusion of COMBINE analysis regression models provided improved rankings for the identification of structurally related molecules in external sets. In our best case, a recognition rate of approximately 80% of known binders at approximately 15% false positives rate was achieved, corresponding to an enrichment factor of approximately 450% over random.

[1]  Sung-Hou Kim,et al.  Structural basis for chemical inhibition of human blood coagulation factor Xa. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Leadley Coagulation factor Xa inhibition: biological background and rationale. , 2001, Current topics in medicinal chemistry.

[3]  L. Chi,et al.  Recent advances in clinical trials of the direct and indirect selective Factor Xa inhibitors , 2000, Expert opinion on investigational drugs.

[4]  A. N. Jain,et al.  Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites. , 1996, Chemistry & biology.

[5]  D. Agrafiotis,et al.  Combinatorial informatics in the post-genomics era , 2002, Nature Reviews Drug Discovery.

[6]  Hans Matter,et al.  Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor Xa. , 2002, Journal of medicinal chemistry.

[7]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[8]  Ajay N. Jain Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.

[9]  Christopher W. Murray,et al.  The sensitivity of the results of molecular docking to induced fit effects: Application to thrombin, thermolysin and neuraminidase , 1999, J. Comput. Aided Mol. Des..

[10]  Biserka Kojić-Prodić,et al.  A quantitative model for predicting enzyme enantioselectivity: application to Burkholderia cepacia lipase and 3-(aryloxy)-1,2-propanediol derivatives. , 2002, Journal of molecular graphics & modelling.

[11]  Ferran Sanz,et al.  3D-QSAR methods on the basis of ligand–receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands , 2000, J. Comput. Aided Mol. Des..

[12]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[13]  A. Spada,et al.  Crystal structures of human factor Xa complexed with potent inhibitors. , 2000, Journal of medicinal chemistry.

[14]  V. Mikol,et al.  The use of 3D structural data in the design of specific factor Xa inhibitors. , 2001, Current topics in medicinal chemistry.

[15]  A. Ortiz,et al.  Evaluation of docking functions for protein-ligand docking. , 2001, Journal of medicinal chemistry.

[16]  F. Javier Luque,et al.  Ligand-induced changes in the binding sites of proteins , 2002, Bioinform..

[17]  Daniel L Cheney,et al.  Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity. , 2002, Bioorganic & medicinal chemistry letters.

[18]  J R Pruitt,et al.  Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1. , 1999, Journal of medicinal chemistry.

[19]  D L Cheney,et al.  Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor Xa. , 1999, Journal of medicinal chemistry.

[20]  Jonas Boström,et al.  Reproducing the conformations of protein-bound ligands: A critical evaluation of several popular conformational searching tools , 2001, J. Comput. Aided Mol. Des..

[21]  W R Ewing,et al.  The design of competitive, small-molecule inhibitors of coagulation factor Xa. , 2001, Current topics in medicinal chemistry.

[22]  D. R. Holland,et al.  Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors. , 2000, Journal of medicinal chemistry.

[23]  Gisbert Schneider,et al.  Virtual screening and fast automated docking methods. , 2002, Drug discovery today.

[24]  Osvaldo Olmea,et al.  MAMMOTH (Matching molecular models obtained from theory): An automated method for model comparison , 2002, Protein science : a publication of the Protein Society.

[25]  G. Klebe,et al.  Approaches to the Description and Prediction of the Binding Affinity of Small-Molecule Ligands to Macromolecular Receptors , 2002 .

[26]  M Pastor,et al.  Comparative binding energy (COMBINE) analysis of human neutrophil elastase inhibition by pyridone-containing trifluoromethylketones. , 2001, Combinatorial chemistry & high throughput screening.

[27]  Rowland Rs Using X-ray crystallography in drug discovery. , 2002 .

[28]  M. Whitlow,et al.  Design, synthesis, and in vitro biological activity of indole-based factor Xa inhibitors. , 2000, Bioorganic & medicinal chemistry letters.

[29]  Natasja Brooijmans,et al.  Molecular recognition and docking algorithms. , 2003, Annual review of biophysics and biomolecular structure.

[30]  M Pastor,et al.  Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design. , 1998, Journal of medicinal chemistry.

[31]  M Pastor,et al.  Simulation of alternative binding modes in a structure-based QSAR study of HIV-1 protease inhibitors. , 1997, Journal of molecular graphics & modelling.

[32]  Marcel L. Verdonk,et al.  Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase , 2002, J. Comput. Aided Mol. Des..

[33]  R C Wade,et al.  Nuclear receptor-DNA binding specificity: A COMBINE and Free-Wilson QSAR analysis. , 2000, Journal of medicinal chemistry.

[34]  Quan Ml,et al.  The design and synthesis of noncovalent factor Xa inhibitors. , 2001 .

[35]  R. Wexler,et al.  The design and synthesis of noncovalent factor Xa inhibitors. , 2001, Current topics in medicinal chemistry.

[36]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[37]  Thomas Lengauer,et al.  Evaluation of the FLEXX incremental construction algorithm for protein–ligand docking , 1999, Proteins.

[38]  Gerhard Klebe,et al.  Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures , 1994, J. Chem. Inf. Comput. Sci..

[39]  Jonathan W. Essex,et al.  A review of protein-small molecule docking methods , 2002, J. Comput. Aided Mol. Des..

[40]  G. Klebe,et al.  Knowledge-based scoring function to predict protein-ligand interactions. , 2000, Journal of molecular biology.

[41]  R. Wade,et al.  Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes. , 2001, Journal of medicinal chemistry.

[42]  Pierre Baldi,et al.  Assessing the accuracy of prediction algorithms for classification: an overview , 2000, Bioinform..

[43]  M Pastor,et al.  Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors. , 1997, Journal of medicinal chemistry.

[44]  P. Lam,et al.  Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa. , 2001, Journal of medicinal chemistry.

[45]  S. Wold,et al.  The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses , 1984 .

[46]  Sébastien Maignan,et al.  Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket. , 2003, Journal of medicinal chemistry.

[47]  Ting Wang,et al.  Comparative binding energy (COMBINE) analysis of OppA-peptide complexes to relate structure to binding thermodynamics. , 2002, Journal of medicinal chemistry.

[48]  J A McCammon,et al.  Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.

[49]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[50]  R. Wade,et al.  Prediction of drug binding affinities by comparative binding energy analysis. , 1997, Journal of medicinal chemistry.

[51]  Joseph J. Barchi,et al.  New Paradigms in Drug Design and Discovery , 2004 .

[52]  Meir Glick,et al.  Docking of flexible molecules using multiscale ligand representations. , 2002, Journal of medicinal chemistry.

[53]  P. Kollman,et al.  Atomic charges derived from semiempirical methods , 1990 .

[54]  Gennady M Verkhivker,et al.  Exploring the energy landscapes of molecular recognition by a genetic algorithm: analysis of the requirements for robust docking of HIV-1 protease and FKBP-12 complexes. , 1996, Proteins.

[55]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[56]  R. Rowland Using X-ray crystallography in drug discovery. , 2002, Current opinion in drug discovery & development.

[57]  J. Gasteiger,et al.  FROM ATOMS AND BONDS TO THREE-DIMENSIONAL ATOMIC COORDINATES : AUTOMATIC MODEL BUILDERS , 1993 .

[58]  Sung-Hou Kim,et al.  Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa. , 2000, Biochemistry.

[59]  P. Kollman,et al.  How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000 .

[60]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1978, Archives of biochemistry and biophysics.

[61]  James J. P. Stewart,et al.  MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..

[62]  I. Kuntz,et al.  Flexible ligand docking: A multistep strategy approach , 1999, Proteins.

[63]  R. Knabb,et al.  Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 2. , 1999, Journal of Medicinal Chemistry.

[64]  R C Wade,et al.  Comparative binding energy analysis of the substrate specificity of haloalkane dehalogenase from Xanthobacter autotrophicus GJ10. , 2001, Biochemistry.

[65]  J Andrew McCammon,et al.  Protein flexibility and computer-aided drug design. , 2003, Annual review of pharmacology and toxicology.

[66]  J. A. Kyle,et al.  Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity. , 2000, Journal of Medicinal Chemistry.

[67]  S. Buchanan Structural genomics: bridging functional genomics and structure-based drug design. , 2002, Current opinion in drug discovery & development.

[68]  J. Venter,et al.  Sequencing the entire genomes of free-living organisms: the foundation of pharmacology in the new millennium. , 2000, Annual review of pharmacology and toxicology.

[69]  Ruth Nussinov,et al.  Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.

[70]  Y. Hosaka,et al.  Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as a factor Xa inhibitor II. Substituent effect on biological activities. , 2002, Chemical & pharmaceutical bulletin.